Richard Schlegel

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Oncology Research. Top assignees: Georgetown University, University of Colorado. Active years: 1996-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Schlegel. Retrieved from https://idiyas.com/inventor/richard-schlegel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 7)

% Patents Active = 93.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 39(Granted Patents)

Company Filing History:

15 out of 499

Georgetown University

patents

1 out of 1,453

University of Colorado

patents

where one patent can have more than one assignee

Years Active: 1996-2024

Loading Chart...

Areas of Expertise:

Artemisinin

Tumor Treatment

Oncogenic Viruses

Epithelial Cells

Papillomavirus Vaccines

Viral Capsid Proteins

Gene Therapy

Human Papilloma Virus

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12128024 - Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections (2024-10-29),

2. 11001808 - Immortalization of epithelial cells and methods of use (2021-05-11),

3. 10041048 - Immortalization of epithelial cells and methods of use (2018-08-07),

4. 9951315 - Immortalization of epithelial cells and methods of use (2018-04-24),

5. 9657272 - Immortalization of epithelial cells and methods of use (2017-05-23),

6. 9279106 - Immortalization of epithelial cells and methods of use (2016-03-08),

7. 8940787 - Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections (2015-01-27),

8. 8394849 - Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections (2013-03-12),

9. 8012679 - Papillomavirus vaccines (2011-09-06),

10. 7989491 - Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections (2011-08-02),

11. 7279306 - Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof (2007-10-09),

12. 6887478 - Formalin-treated human papillomavirus L1 protein vaccine (2005-05-03),

13. 6485728 - Formalin-Inactivated human papillomavirus L1 protein vaccine (2002-11-26),

14. 5874089 - Protecting against canine oral papillomavirus (copy) (1999-02-23),

15. 5576206 - Human papilloma virus genes and their use in gene therapy (1996-11-19),

**Title: The Innovative Journey of C. Richard Schlegel**

Introduction:

C. Richard Schlegel, a distinguished inventor hailing from Rockville, MD (US), has made significant contributions to the field of science and technology through his groundbreaking innovations.

Latest Patents:

C. Richard Schlegel holds several patents in the areas of biotechnology and medical research, showcasing his commitment to advancing these fields with his inventive solutions.

Career Highlights:

With a career spanning several decades, C. Richard Schlegel has been at the forefront of cutting-edge research, particularly in the development of novel technologies aimed at improving healthcare outcomes and diagnostics.

Collaborations:

Throughout his career, C. Richard Schlegel has collaborated with leading experts in the industry, fostering a culture of innovation and knowledge-sharing that has led to remarkable advancements in the field.

Conclusion:

In conclusion, C. Richard Schlegel's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his reputation as a pioneering inventor in the realm of biotechnology and medical research.

Profile summary based on public USPTO records.